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Introduction
Chronic wounds are characterised by a high 
bacterial count, the presence of more than 
one bacterial strain, the increased tendency 
to harbour drug-resistant organisms and the 
presence of biofilms (Vowden et al, 2008).  This 
can delay wound healing and make these wounds 
difficult for nurses to manage.  Cutimed Sorbact 
dressings irreversibly bind bacteria and fungi and 
offer an alternative approach to the management 
of bioburden (Hampton, 2007; Kammerlander 
et al, 2008).  Cutimed Sorbact dressings are 
coated with a fatty acid derivative DACC (dialkyl 
carbamoyl chloride), providing the product 
with strong hydrophobic properties.  Wound 
pathogens also have hydrophobic characteristics, 
therefore they become irreversibly bound to 
the fibres of the dressing in a moist wound 
environment. Cutimed Sorbact has no local 
antiseptic or antibiotic agent impregnated into 
the dressing.  This is a useful innovation as there 
is no donation of chemicals, which could lead to 
resistance or adverse side effects. This means the 
dressings can be safely used for longer than a 2 
week period (Haycocks, 2011).
Method
A Cutimed Sorbact evaluation was undertaken 
on two patients within the vascular clinic. The 
patients chosen for the evaluation were showing a 
lack of healing progression which was thought to 
be a result of high bacterial load.
Case Study One
Mr S underwent amputation of his right great, 2nd 
and 3rd toes due to diabetic neuro / ischaemia 
ulceration; at the time of amputation he had 
undergone successful revascularisation.  The 
majority of the wound healed well but the lower 
end of the wound dehisced leaving an open area 
of approximately 4 x 3 cm which became sloughy. 
Within two weeks the slough was successfully 
debrided with the use of moist hydrofibre but 
then healing became static with a no evidence of 
advancing wound edges (Fig.1).  The wound bed 
was clean but had fragile granulation tissue and 
some malodour, therefore, it was thought that 
high bacterial load was hindering wound healing.  
Topical silver dressings were used but with little 
effect.  He was seen in the Vascular Clinic 8 
weeks post amputation and was commenced 
on Cutimed Sorbact with the aim of reducing the 
bacterial load and promoting healing.
Results
After using Cutimed Sorbact for only 2 weeks, the 
bacterial load appeared to be reducing and the 
wound edges started to advance, after 6 weeks 
use the wound had almost completely healed 
(Fig.2).
Case Study Two
Mrs T underwent left forefoot amputation due 
to a severe diabetic foot infection.  Magnetic 
Resource Angiograms were undertaken and 
showed that there was no significant evidence of 
peripheral arterial disease. The wound dehisced 
on the lateral edge on removal of sutures.  In 
clinic 10 weeks post amputation there was 
evidence of superficial slough and the wound 
had moderate levels of exudate which had a 
significant malodour; the wound edges appeared 
static.  The wound had been previously dressed 
with cadexomer iodine paste which did not 
appear to be controlling the bacterial level to allow 
healing to occur; therefore Cutimed Sorbact was 
commenced (Fig.3).
Results
Within 2 weeks of commencing Cutimed Sorbact 
there was evidence of improvement on the wound 
bed and at review 6 weeks later total healing had 
occurred (Fig.4).
Conclusion
Cutimed Sorbact was found to be an effective 
treatment for the management of wounds 
showing signs of delayed healing due to increased 
bacterial load.  In these case studies Cutimed 
Sorbact was found to be effective where other 
antimicrobial dressings failed to have an impact 
on wound healing.  Furthermore, often high risk or 
hard to heal patients require longer antimicrobial 
therapy than the currently recommended 2 weeks 
duration (Wounds UK, 2010). Due to the fact that 
Cutimed Sorbact dressings do not donate any 
chemicals into the wound bed it could therefore 
be a useful tool for those wounds that require 
longer antimicrobial therapy.
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